Vaccine-induced immunity
[용어속성] Action
A quick scoping review of the first year of vaccination against the COVID-19 pandemic: Do we need more shots or time?
Article
[키워드] acute respiratory syndrome
Adequate
administration
benefit
booster
booster dose
booster vaccinations
Breakthrough infection
conducted
coronavirus
coronavirus disease
COVID-19
COVID-19 vaccination
COVID-19 vaccine
debates
demonstrated
dose
Effect
ENhance
Evidence
General population
healthcare
Immunity
Immunocompromised patient
individuals
information
Initially
lack
maintain
neutralizing antibody
pandemic
raised
reported
required
Safe
second dose
the vaccine
trajectory
vaccination
Vaccine
Vaccine-induced immunity
variants
Viral variants
waning immunity
[DOI] 10.1097/MD.0000000000030609 PMC 바로가기
[DOI] 10.1097/MD.0000000000030609 PMC 바로가기
Loss of Pfizer (BNT162b2) Vaccine-Induced Antibody Responses against the SARS-CoV-2 Omicron Variant in Adolescents and Adults
Article
[키워드] Adolescent
adolescents
adolescents and adult
adolescents and adults
Adults
age
antibody
Antibody binding
antibody binding titers
approved
Beta
binding
binding antibody
BNT162b2
BNT162b2 vaccine
booster
booster dose
booster vaccination
breadth
changes in
children
circulating
clinical trial
Cohort
Coverage
COVID-19
Delta
demonstrated
dose
drug
Effectiveness
Efficacy
evaluate
FDA
food
Gamma
highlight
Hospitalization
humoral immune response
lack
less
Loss
magnitude
mounted
mRNA vaccine
neutralization
Neutralizing antibody response
omicron
Omicron (B.1.1.529)
pandemic
pediatric
Pfizer
Pfizer-BioNTech
Pfizer-BioNTech (BNT162b2)
plasma
populations
PROTECT
reduction
reported
Research
response
responses against
robust
SARS-CoV-2
seasonal beta coronavirus
the antibody response
the SARS-CoV-2
the vaccine
vaccination
Vaccine
vaccine-induced antibody response
Vaccine-induced immunity
variant
variant of concerns (VOCs)
variants
viral variant
Virus neutralization
virus spike protein
VoC
VOCs
while
wild-type SARS-CoV-2
[DOI] 10.1128/jvi.00582-22 PMC 바로가기
[DOI] 10.1128/jvi.00582-22 PMC 바로가기
Breakthrough infections with the omicron and delta variants of SARS-CoV-2 result in similar re-activation of vaccine-induced immunity
Article
[키워드] antibody
archive
authority
Breakthrough infection
cellular
cellular immunity
Coalition
Council
Delta
delta variant
early immune response
European
healthy controls
Horizon
Human
immune response
in healthy individual
increase in
individual
Infection
Inflammatory mediators
inflammatory parameters
information
interferon gamma
median time
Mild
Neutralizing activity
Norway
Nucleocapsid proteins
omicron
Patient
Protein
RBD
Regional
Result
SARS-CoV-2
sera
symptom onset
the receptor-binding domain
the SARS-CoV-2
university
vaccinated individual
vaccinated individuals
Vaccine
vaccine dose
Vaccine-induced immunity
variant
Whole blood
[DOI] 10.3389/fimmu.2022.964525 PMC 바로가기
[DOI] 10.3389/fimmu.2022.964525 PMC 바로가기
Cheminformatics-Based Discovery of Potential Chemical Probe Inhibitors of Omicron Spike Protein
Article
[키워드] ACE2
Antiviral compound
antiviral drug
authorization
bind
carried
Chemical
Compound
compounds
COVID-19
COVID-19 pandemic
database
determine
DFT
drug treatment
effective
Emergency
evaluate
facilitate
FDA
FIVE
Health
human Angiotensin-converting enzyme
identify
IMPROVE
in vitro
in vivo
indicated
Initially
Invasion
less
Lineage
MD simulation
molecular
monoclonal antibody
mutant
neutralizing monoclonal antibody
omicron
Potential
profile
Protein
protein-ligand interaction
provided
raised
reactivity
receptor
reduce
Reinfection
Replication
rising
risk
SARS-CoV-2
SARS-CoV-2 variant
SARS-CoV-2 variants
spike
Spread
the Spike
therapeutic intervention
vaccination
Vaccine-induced immunity
variant
Virtual screening
virus
virus transmission
was performed
[DOI] 10.3390/ijms231810315 PMC 바로가기
[DOI] 10.3390/ijms231810315 PMC 바로가기
A severe presentation of breakthrough infection caused by the Omicron variant with radiological findings of COVID-19 pneumonia in an elderly woman
Case report
[키워드] booster dose
Breakthrough infection
caused
characterized
Chest computed tomography
COVID-19
COVID-19 infection
defined
Dyspnea
elderly
Elderly patient
exceptional
highlight
immune evasion
immunosenescence
infect
knowledge
lung involvement
mRNA vaccine
omicron
Omicron variant
Patient
patients
Pneumonia
polymerase chain
positive
radiological finding
remained
reported
the patient
Transmissibility
Vaccine-induced immunity
Vaccines
variant
virus variants
[DOI] 10.1016/j.radcr.2022.06.034 [Article Type] Case report
[DOI] 10.1016/j.radcr.2022.06.034 [Article Type] Case report
Preserved recognition of Omicron spike following COVID-19 messenger RNA vaccination in pregnancy
임신 중 COVID-19 메신저 RNA 백신 접종 후 오미크론 스파이크의 보존된 인식
Article
Published on
Journal: American journal of obstetrics and gynecology [Category] COVID19(2023년), MERS, SARS, 변종, 진단,
Journal: American journal of obstetrics and gynecology [Category] COVID19(2023년), MERS, SARS, 변종, 진단,
[키워드] administration
analyzed
antibodies
antibody
attenuate
binding
center
Complete
Control
COVID-19
COVID-19 vaccine
COVID-19 vaccines
disease
disease control
disease course
disease severity
during pregnancy
Efficacy
Evolution of SARS-CoV-2
Fc receptor
Fc receptors
Fcγ receptor
full dose regimen
Immunoglobulin
immunoglobulin M
Infection
Luminex assay
Messenger RNA
Moderna
mRNA
mRNA vaccine
mRNA-1273
neutralization
Neutralizing activity
Neutralizing antibodies
obstetrics
omicron
Omicron variant
organization
Pfizer/BioNTech
Pregnancy
pregnant women
preserved
prevention
PROTECT
raised
receiving
receptor
Receptor binding
Receptor binding domain
reduce
reduced
remained
SARS-CoV-2
SARS-COV-2 infection
SARS-CoV-2 variants
severe disease
Spike-specific antibody
These data
vaccinated individuals
vaccination
Vaccine
vaccine efficacy
vaccine-induced antibodies
vaccine-induced antibody
Vaccine-induced immunity
variant
variants
variants of concern
[DOI] 10.1016/j.ajog.2022.04.009 PMC 바로가기 [Article Type] Article
[DOI] 10.1016/j.ajog.2022.04.009 PMC 바로가기 [Article Type] Article
A comprehensive insight into current control of COVID-19: Immunogenicity, vaccination, and treatment.
Review
Published on
Journal: Biomedicine & pharmacotherapy = Biomédecine & phar [Category] SARS, 변종, 비임상, 유전자 메커니즘, 임상, 진단, 치료법, 치료제,
Journal: Biomedicine & pharmacotherapy = Biomédecine & phar [Category] SARS, 변종, 비임상, 유전자 메커니즘, 임상, 진단, 치료법, 치료제,
[키워드] addition
administration
antibody
Antiviral
antiviral agent
antiviral drug
approved
cellular
combined treatment
Complex network
Complication
conditions
COVID-19
COVID-19 infection
COVID-19 vaccinations
critical COVID-19 patient
Cytokine release syndrome
Delta
determinant
effective
Efficacy
extrinsic
healthy
humoral
immune memory
immune system
immunogenicity
Immunological response
immunomodulators
immunomodulatory drug
indicate
Inflammation
Inflammatory response
intrinsic
lactoferrin
maintain
mechanisms
Medicine
monoclonal antibody
natural
Occurrence
offer
omicron
parameter
parameters
pathogen
PROTECT
reduce
relative contribution
Remdesivir
SARS-CoV-2
SARS-CoV-2 variants
Side effects
specific disease
Stage
the vaccine
tissue
tissue homeostasis
transmissible variant
Treatment
treatment trial
vaccination
Vaccine
vaccine responses
Vaccine-induced immunity
WHO
widespread
World Health Organization
[DOI] 10.1016/j.biopha.2022.113499 [Article Type] Review
[DOI] 10.1016/j.biopha.2022.113499 [Article Type] Review
Impaired immunity and high attack rates caused by SARS-CoV-2 variants among vaccinated long-term care facility residents
Article
[키워드] acute respiratory syndrome
addressed
Alpha variant
antibody
attack rate
B.1.1.7
B.1.351
Beta
Breakthrough infection
Care
caused
cell-mediated immune response
Cell-mediated immunity
concentrations
coronavirus
COVID-19
COVID-19 outbreak
COVID-19 vaccination
elderly
HCWs
healthcare worker
high risk
IgG
Immunity
Immunoglobulin
Impaired
investigated
Long-term care
Long-term care facility
marker
NAb titer
Neutralizing antibodies
neutralizing antibody
outbreak
protocols
SARS-CoV-2 variant
second dose
severe coronavirus disease
spike glycoprotein
susceptible
vaccination
vaccine doses
vaccine response
Vaccine-induced immunity
variant
variants
[DOI] 10.1002/iid3.679 PMC 바로가기
[DOI] 10.1002/iid3.679 PMC 바로가기
SARS-CoV-2 Reinfection Rate and Outcomes in Saudi Arabia: A National Retrospective Study
Article
Published on
Journal: International Journal of Infectious Diseases [Category] COVID19(2023년), SARS, 변종,
Journal: International Journal of Infectious Diseases [Category] COVID19(2023년), SARS, 변종,
[키워드] 95% CI
95% confidence interval
Analysis
B.1.617.2
Care
Cohort
Comorbidities
concern
control group
COVID-19 vaccine
defined
demographics
disease
dose
effective
first dose
Health
HIV
individual
Infection
majority
Mortality
multivariate logistic regression
National
naturally acquired immunity
negative test
obesity
Odds ratio
participant
Positive test
Pregnancy
protective immunity
provided
Rate
Reinfection
Result
retrospective
risk factor
SARS-CoV-2
SARS-CoV-2 disease
SARS-CoV-2 reinfection
SARS-CoV-2 test
SARS-CoV-2 variant
SARS-CoV-2 variants
Saudi Arabia
second dose
severe disease
severe SARS-CoV-2
subject
transmissible variant
vaccination
Vaccine-induced immunity
variant
variant of concern
[DOI] 10.1016/j.ijid.2022.07.025 PMC 바로가기
[DOI] 10.1016/j.ijid.2022.07.025 PMC 바로가기